Pharmacokinetics and pharmacodynamics of JR-051, a biosimilar of agalsidase beta, in healthy adults and patients with Fabry disease: Phase I and II/III clinical studies-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of JR-051, a biosimilar of agalsidase beta, in healthy adults and patients with Fabry disease: Phase I and II/III clinical studies

Published:2020-07 Issue:3 Volume:130 Page:215-224
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Nakamura Kimitoshi,Kawashima Satoshi,Tozawa Hirotaka,Yamaoka Mariko,Yamamoto Tatsuyoshi,Tanaka Noboru,Yamamoto Ryuji,Okuyama Torayuki,Eto Yoshikatsu

Funder

JCR Pharmaceuticals Co.,Ltd

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. α-Galactosidase A deficiency: Fabry disease;Desnick,2001

2. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease;Eng;N. Engl. J. Med.,2001

3. Fabry disease;Kobayashi,2012

4. Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy;van Breemen;Biochim. Biophys. Acta,2011

5. Plasma lyso-Gb3: a biomarker for monitoring Fabry patients during enzyme replacement therapy;Sakuraba;Clin. Exp. Nephrol.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice;Molecular Genetics and Metabolism Reports;2024-09

2. Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments;Pharmaceutical Medicine;2024-04-29

3. Anderson–Fabry disease management: role of the cardiologist;European Heart Journal;2024-03-15

4. Novel Biomarkers of Cardiovascular Disease;Comprehensive Precision Medicine;2024

5. Treatment of Fabry Nephropathy: A Literature Review;Medicina;2023-08-17